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Abstract
Background: Increasing healthcare costs need to be contained in order to maintain
equality of access to care for all EU citizens. A cross-disciplinary consortium of
experts was supported by the EU FP7 research programme, to produce a roadmap on
cost containment, while maintaining or improving the quality of healthcare. The
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roadmap comprises two drivers: person-centred care and health promotion; five critical enablers also need to be addressed: information technology, quality measures,
infrastructure, incentive systems, and contracting strategies.
Method: In order to develop and test the roadmap, a COST Action project was initiated: COST CARES, with 28 participating countries. This paper provides an overview
of evidence about the effects of each of the identified enablers. Intersections
between the drivers and the enablers are identified as critical for the success of
future cost containment, in tandem with maintained or improved quality in
healthcare. This will require further exploration through testing.
Conclusion: Cost containment of future healthcare, with maintained or improved
quality, needs to be addressed through a concerted approach of testing key factors.
We propose a framework for test lab design based on these drivers and enablers in
different European countries.
KEYWORDS

cost containment, health economics, health policy, health promotion, health service preventive,
person-centred care, quality of care
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B A CKG R O U N D

and health promotion, with examples, before setting out a framework
for the design of test labs to put the roadmap into practice.

The European Council has agreed on several values and principles
regarding healthcare systems that are shared across the member
states. These values include universality, access to good quality care,

2
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P ER S O N - C E N T R E D C A R E

equity, and solidarity.1
At that time, costs or affordability were not explicitly addressed,

The core component in PCC emphasizes the patient as a person in

although these are important issues in any system whose aim is to

order to involve that person as a “partner.” in his/her own care and

safeguard these common values.

treatment. PCC is a shift away from a model, in which the patient is

The Council also stated that it is essential to make European

the passive target of a medical intervention, to an approach character-

healthcare systems financially sustainable in a way that protects

ized by a “more mutual agreement,” in which the patient is an active

future healthcare. However, expenditure for health in all European

partner in their own care and in the decision-making process of the

Union (EU) countries between 2000 and 2009 increased from 8.0% to
10.0% of the gross domestic product (GDP), and in the “old” EU-15
countries alone, from 8.7% to 10.6%.2
In order to address important challenges affecting the future of
European Health Care, a project, WE CARE funded by the FP7 programme, was initiated in 2013 and was finished in 2015.
During the final conference in April 2015, the WE CARE consortium presented its summary report “Healthcare innovations and
improvements in a financially constrained environment: Strategy Plan
and R&D Roadmap”.3,4 This report included a roadmap, which proposed a new strategic plan embedding seven interdependent themes,
responsible for facilitation of a breakthrough in cost containment
while, at the same time, improving the quality of care. These themes
fell into two categories: (a) two drivers, which form the “backbone” of
the strategic plan: person-centred care (PCC) and health promotion
and (b) five critical enablers, which are aspects of the macro environment that influence the implementation of these drivers: information
technology, quality measures, infrastructure, incentive systems, and
contracting strategies (Figure 1). In this paper, we explicate both PCC

F I G U R E 1 Interdependencies of macro and micro enablers and
the two central innovations close to the individual (modified from WE
CARE3,4 with permission)
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care and treatment plan. Co-creation of care in the form of partner-
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ship between the patient, their family, and carer(s), and the team of
health professionals caring for them, is the core component of PCC, a

PCC represents a movement that has an explicit focus on humanizing

concept that is becoming widely used.5-7

health services and ensuring that the patient is an equal partner in

PCC embodies and enacts the philosophy and ethics applied in

their own care and treatment above and beyond care according to

the Capability Approach, which has been used as a theoretical frame

evidence based medicine. In this context, the body of evidence

of reference in several research disciplines, for example, in economics

supporting the processes and outcomes associated with person-

by the Nobel laureate Amartya Sen.8

centeredness in health and social care is constantly growing. In the

PCC is the concept used in this project and is distinct from

cardiovascular field, PCC interventions with patients hospitalized for

patient-centered care, because the word “patient” tends to objectify

chronic heart failure are associated with reduced length of hospital

and reduce the person to a mere recipient of medical services, or to

stay, a better discharge process, and reduced patient uncertainty

“one who is acted on”.6 Today, patients often have to navigate

about their disease and treatment.12-14 Other outcomes include

through a fragmented healthcare system and adapt to the usual prac-

reduced healthcare costs and maintained functional performance.15

tices of healthcare organizations and professionals, rather than receiv-

Furthermore, other studies involving patients with severe chronic

ing care designed to focus on the individual patient's resources and

heart failure and evaluating the core components of PCC described

needs, preferences, and values.9

above found fewer hospitalizations and improved quality of life

The World Health Organization (WHO) uses the term “people-

(QoL).16 For patients with acute coronary syndrome (ACS), a random-

centered health services” which is an approach to care that

ized controlled trial (RCT) indicated that a PCC approach was effective

consciously adopts the perspectives of individuals, families, and

in increasing self-efficacy over the whole care chain (from hospital to

communities and sees them as participants as well as beneficiaries

primary care).17-19 In particular, patients with lower education

of trusted health systems that respond to their needs and preferences

increased their self-efficacy significantly more than patients with a

in humane and holistic ways.

higher level of education.20 A follow-up randomized controlled trial
showed lasting effects of PCC after an ACS event over the 2-year
study period.18

2.1
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How can person-centred care be applied?

Thus, the evidence demonstrates that PCC has the potential to
combine high-quality evidence based care with controlled costs, in

In PCC, patients and healthcare professionals jointly develop a

alignment with the aims of WE CARE and COSTCARES.

healthcare plan based on the patient´s illness history and future goals,
which identify personal resources and opportunities as well as potential barriers and needs.5-7

3
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HEALTH PROM OTIO N

One of the fundamentals of PCC is the formation of a partnership
between the patient and professionals. However, there is an asymme-

The second key driver besides PCC is health promotion. Multiple

try between the professional and patient. Professionals are usually in

definitions for health promotion have been proposed since the term

a more powerful position, as they possess greater knowledge of their

was introduced in the 1970s. One of the first definitions was given by

This implies that there

Lalonde, the Canadian health minister in 1974 as “a strategy aimed at

cannot be a symmetrical exchange. However, a one-way exercise of

informing, influencing and assisting both individuals and organizations so

power cannot be ethically justified and will not serve either the

that they will accept more responsibility and be more active in matters

patient or the professional. To establish a partnership requires an

affecting mental and physical health”.21 The Ottawa Charter for Health

involvement from both parties but from different starting points and

promotion later defined Health Promotion as “the process of enabling

with different prerequisites. The health professional is an expert in

people to increase control over, and to improve their health”.22

10

specialization than the patients they serve.

medicine, rehabilitation, nursing, and so on, and the patient is an

Targets for health promotion are primarily noncommunicable

expert on their own life. A partnership thus demands that the patient

diseases (NCDs), which are identified as the leading causes of

is treated as a person, who is simultaneously capable, vulnerable,

mortality and have several modifiable, behavioral risk factors includ-

dependent, as well as independent.

ing excessive alcohol use, physical inactivity, tobacco use, and poor

In summary, PCC is operationally defined as co-creation of care
between the patients, patient proxies if appropriate, and health
6,7,11

professionals.

The fundamentals have been defined into three core components
of PCC by Ekman et al.6

diet. Biological risk factors include high blood pressure, diabetes, and
obesity.23
Health promotion should be carried out on different levels to be
effective, both population-wide (eg, taxes, mass media campaigns,
school programs) and individual, but there is uncertainty in which
components are more effective. There is also a gap in research evi-

1. Initiating the partnership through the patient narratives.
2. Working the partnership by creating a health plan in agreement.
3. Safeguarding the partnership by documenting the health plan.

dence from low- and middle-income countries.24,25
One very important principle of health promotion is empowerment, that is, seeking to ensure that individuals have the power to

&C?JRFѥ1AGCLACѥ0CNMPRQ
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affect their own health. This aligns closely with the principles of

healthcare professionals, policy makers, and patient representatives in

PCC. Other important criteria include participation and having a

healthcare to achieve cost containment and quality research. COST-

broad perspective of health and inequality. Health promotion has

CARES sets out to tackle these challenges by:

gained recognition in recent years because of the growing evidence on the importance of lifestyle behavior for individual
health.26,27 In addition, socioeconomic conditions, as well as social
and structural support, have been identified as important determinants of health. Thus, addressing public health in the modern era
includes lifestyle behavioral changes based on a bio-psycho-social
model.28

1. Working toward the development of care systems based on PCC
and health promotion that can be tested on a macro level.
2. Defining the parameters necessary to perform and evaluate largescale implementation.
3. Executing studies that will provide an adequate evidence base for
PCC and health promotion across various contexts in different

There are clear similarities between health promotion and PCC,

countries.

for instance, the emphasis on identifying and supporting the individual's resources to influence their own health and the focus on the

WE CARE posits the notion that cost containment and quality ini-

societal context affecting this process. A key component is tailoring

tiatives, although inextricably linked, should also be considered from a

the process to each person, exemplified by the identification of

person-centered micro level including the elements of healthcare

barriers and facilitators, unique to the individual, as well as the

which support preventative/health promoting strategies.3 It is impor-

importance of the social environment for such changes to take place,

tant to consider the interdependent macro-level enabling factors

for example, positive/negative reinforcement by relatives or the

including: information technology, quality measures, infrastructure,

surrounding community.

incentive systems, and contracting strategies (Figure 1).

Health promotion is included in the context of WE CARE and

The precise design of each test lab requires a particular combina-

COSTCARES because it represents high-quality interventions that

tion of enabling factors, underpinned by a rationale explaining how

keep populations healthy and, at the same time, means that

they would improve PCC and health promotion.

healthcare is less costly for society. Health promotion and PCC are

The hypothesized enablers in the WE CARE roadmap can be used

key drivers to cap healthcare costs, while simultaneously maintaining

to develop implementation strategies to overcome barriers for the

or improving the quality of care and resulting improved health for all.

effective implementation of PCC and health promotion. Just as clinical
interventions are studied in randomized controlled trials, research
designs exist to study the effectiveness of implementation strategies

4
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in a real-life setting. Implementation strategies, which will likely
involve one or more enablers, can be implemented sequentially, con-

In order to carry forward the WE CARE roadmap, Cost Action

currently, or in an isolated fashion (depending on the programme the-

(CA) 15222 was initiated in 2017 with the project name COSTCARES.

ories to be tested). As the test lab sites will be geographically, socially,

The main aim of COSTCARES is to establish processes for

and economically disparate, the implementation strategies and role of

implementing PCC and a working framework for evaluation test labs

specific enablers will differ.29,30 What will be common to all test labs,

of PCC and health promotion in different countries. These test

however, is the monitoring of the core components of the PCC or

labs are essential to the effort necessary to expand the evidence base

health promotion intervention. Existing evidence to support the WE

regarding how PCC and health promotion drive cost containment in

CARE roadmap framework for implementation of PCC and health pro-

healthcare while maintaining and improving quality of care in various

motion as part of the COSTCARES project is defined and discussed

settings and countries. The work in COSTCARES is managed in four

below.

working groups (WGs) (See Appendix S1). The overall aim of the work

The macro enablers: Each of these enablers is outlined in Figure 2

of WG2 is to define a logistic and organizational framework that is

on the vertical axis and is defined below in line with current evidence

necessary for the design of large-scale testing of PCC systems that

and discourse. In COSTCARES, it was realized that the intersections

will contain costs while maintaining quality of care.

between the enablers and the two drivers identify the core challenges

The WE CARE roadmap was developed by WG2 in reviewing the
existing literature as well as practice. Examples of implementing PCC

in implementing the roadmap from WE CARE. These intersections are
highlighted in Figure 2.

policy and practice in different settings in different countries were

The performance in the intersections between drivers and

also identified and explored. Two successful examples/cases are

enablers has not yet been tested. There are a number of reasons

outlined in Appendix S2.

why it is difficult to develop, test, and scale-up innovative care
models. First, care systems are very complex and often highly fragmented. The model must appease the interests and diverse goals of

5
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FRAMEWORK FOR TEST LAB DESIGN

key stakeholders underpinning the health system. Second, scientific
siloes tend to result in limited interaction between vital disciplines

The test lab(s) in COSTCARES are designed to guide and stimulate the

that include medical and care services, health systems, health eco-

integration and collaboration between academic disciplines, industry,

nomics, health policy, implementation science, medical technology,

SWEDBERG ET AL.
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F I G U R E 2 Details the critical
macro enablers and the intersections
with the person-centred care and
health promotion on the
horizontal axis

information and communications technology (ICT), and communica-

errors), supporting healthcare professionals (eg, timely availability of

tion science. Third, these care models are typically tested in smaller

up-to-date patient information), and collecting patient key information

scale contexts with insufficient examination of the organizational,

(symptom diaries, sensor data, digital peer-to-peer networks). This has

cultural, financial, technical, and legal aspects necessary to imple-

increased the efficiency of care (eg, shorter patient waiting times) or

ment the model on a large scale in a real-world setting. Thus, critical

even improve the quality of patient care.33

evidence to support larger scale implementation is not widely avail-

However, in the field of healthcare, there are also risks associated

able.31 Innovative care models require testing on a macro level to

with information technology: modern information systems are costly

engage policy makers, funding institutions, and care providers

and their failure can have a negative impact on patients and

who can collaborate with multidisciplinary researchers to drive

workers.34

the systematic evaluation and practical implementation of these

The most adequate description of healthcare IT tasks is provided

innovative care models. In order to develop and test such a com-

by the World Health Organization: the health IT is the basis for

plex intervention further, a programme theory is needed. A pro-

decision-making and has four main functions35:

gramme theory is an explanation, or series of linked explanations,
showing how the different components of an intervention work

• data generation,

together to produce specific outcomes. Such a model would

• compilation,

answer the question: “How and why might this intervention (test

• analysis and synthesis,

lab) produce intended outcomes?” In addition, “What are the

• communication and use.

likely mechanisms involved?” Other relevant questions at this
stage include “What existing evidence is there that this interven-

In addition to the integrated role of IT in clinical and diagnos-

tion might work, and can this intervention be fully described?”

tic equipment, it has a unique position to capture, store, process,

The latter would facilitate replication, dissemination, and imple-

and timely transmit information to better coordinate health care

mentation. These questions are answered by using a parallel

at both the individual and population levels. For example, data

process evaluation32 along with implementation questions that

mining and decision-making capabilities can point to potential risk

cover intervention fidelity or adaptation (was the intervention

events for each patient, as well as contribute to the health of the

delivered as intended?), dose (how much of the intervention

population by providing insights into the causes of disease

was delivered?), and reach (how many of the intended recipients

complications.36

actually received the intervention?).

Moreover, ensuring information security and privacy in the

Information technology (IT) encompasses a variety of technolo-

healthcare sector is becoming increasingly important. The adoption

gies that include simple charting, advanced decision support,

of digital patient records, tighter regulation, consolidation of

integration with medical technology, and co-development with

providers, and the growing need for information from patients, pro-

patients, such as mobile applications or patient-accessible elec-

viders, and payers point to the need for better information security.

tronic health records (EHR).

To this end, cyber security must become an integral part of patient

The use of information technology offers great potential for
reducing clinical errors (eg, prescribing errors, disease diagnostic

security. Changing human behavior, technologies, and processes is
part of a holistic solution.37

&C?JRFѥ1AGCLACѥ0CNMPRQ
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One of the most important factors in person-centred care (PCC)

diversity. In time, this may provide service integration and an ade-

and health promotion is addressing new information technology solu-

quate welfare system (eg, support economic growth, subordinate to

tions enhanced by artificial intelligence (AI) to support better, safer,

economic policy).58

and more accessible healthcare.

Incentive systems: There are many types of incentive systems, typ-

The Information System technology vision in healthcare should

ically described as financial vs nonfinancial or direct vs indirect. Good

highlight the changing definition of valuable care, which includes

evidence regarding the effectiveness is lacking because of weak

acute, chronic, and preventive care and patient health wellness

research designs. Financial incentives are most commonly applied and

promotion.38

studied. QOF P4P showed some indication that efficient physicians

Quality measures: In the past 5 years, many studies have been

may be rewarded by the system, but the study did not investigate if

published in the area of quality measures within healthcare include

the overall quality increased.57 In addition, three Cochrane reviews

the following five key dimensions aligned with COSTCARES frame-

concluded that there is insufficient evidence to accept or reject the

work: safety, equality, appropriate, person-centred, and efficiency.

use of financial incentives as a method to improve the quality of

Study designs are varied and include systematic reviews, cross-sec-

care.61-63 Furthermore, the cost-effectiveness of a financial incentive

tional, prospective, and retrospective approaches with a paucity of lit-

model has been questioned.62 Regarding incentive systems for health

39

Thus, future studies should

promotion practices, Town et al64 conducted a systematic review of

consider taking into consideration specific patient safety culture mea-

the impact of financial incentives (defined as direct payments or

surement tools, the level of analysis, and selection of outcome

bonus as well as more diffuse incentives) to providers for preventive

measures.40-46 Current metrics suffer from low reliability and validity

care delivery. They concluded that small rewards are likely not enough

erature regarding the methodology.

47,48

scores,

for example, the Adverse Outcome Index should be modi-

fied to more appropriately measure preventable adverse events.49

to motivate physicians to change their practice behaviors with respect
to preventive care.

Moreover, health professionals, patients, and relatives should be

Furthermore, unintended consequences of introducing finan-

involved in the design and collection of data48,50,51 which should

cial incentives into a healthcare system should be taken into

include patient-reported outcomes, morbidity, and cost,52 for which

account in research design. A checklist is available to determine if a

more recent efforts, such as the Patient-Reported Outcomes Mea-

financial incentive should be used and assist in its design.65

surement Information System (PROMIS) measures, indicate important

According to WHO Guidelines, nonfinancial incentives play an

steps forward.53

equally crucial role in incentive systems.66 Design of an appropriate

Contracting strategies: Many healthcare systems use weighted

incentive system should address to whom incentives are targeted,

capitation mechanisms for payment to general practitioners. In the

ongoing evaluation at multiple levels, and potential unintended

ideal capitation model, several measures such as age, gender, mor-

consequences. It is recommended that incentives systems adhere

bidity, additional health needs, local labor costs, rurality, patient

to the four principles below67:

turnover, and so on can be included and comprehensively examined
to predict patient expenditure and base capitation on the predic-

• fiscally prudent;

tion.54 In Sweden, some argue that the current capitation function

• simple to administer;

or service-purchasing model may contribute to or increase inequal-

• culture of continuous improvement;

ity.

55

Health economics are increasingly interested to expand eval-

• equity in and access to quality care.

uation of cost-effectiveness in integrated care for chronic
conditions.56 In the UK, the Quality and Outcomes Framework
(QOF) pay for performance (P4P) scheme was explored as a poten-

6
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tial model to reward primary care practitioners. Workers who relocate themselves on the basis of their ability may increase

COSTCARES continues to discuss the transfer and scaling up of PCC

productivity and wages in organizations that use P4P scheme.57

and health promotion to different contexts. Test labs will involve vari-

There is a lack of knowledge about the sorting and retention effects

ous alternatives to describe how the intervention and implementation

that P4P may produce.

of the intervention can be appropriately evaluated. In particular,

Infrastructure, service delivery, and organizational models: The fragmentation of services and providers together with shared delivery cre-

COSTCARES is examining system characteristics at the micro, meso,
and macro levels, including:

ates potential risks to the management of healthcare.58-60 In many
national healthcare systems, the financing and operational control

1. Micro—the intervention itself, for example, the types of care pro-

over different parts of the delivery of healthcare is managed by

fessionals engaged in carrying out the intervention and types of

completely separate legal entities. This clearly impacts the utilization
of resources. In addition, a high-quality healthcare system requires a
safe environment with sufficient technical medical equipment.60 From
a fiscal perspective, the focus may be put on public–private partnerships, which can impact on quality, risk management, competition, and

patient groups involved.
2. Meso—type of center, for example, primary care vs hospital
setting.
3. Macro—country and types of healthcare policy and funding
mechanisms.

SWEDBERG ET AL.
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that the fundamentals to this achievement are the drivers: PCC and
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COSTCARES recognizes that in order to sustain the benefits of
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enablers at once and the decision to develop implementation strategies involving certain enablers should be taken together with the
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